Explore more
News
Danaher Q2 Earnings Beat Estimates
Digest more
Danaher Corporation thrives on bioprocessing demand and diagnostics resilience. Click for why, with solid execution and 80% ...
2d
Danaher Corp (DHR) reports robust free cash flow and bioprocessing growth, while navigating global trade tensions and Life ...
Danaher Corp (NYSE:DHR) on Tuesday reported second-quarter 2025 sales of $5.94 billion, up 3.5% year-over-year, beating the ...
Danaher reported generating $1.1 billion in free cash flow during the quarter, with adjusted diluted net earnings per share increasing by approximately 5% year-over-year. This financial strength ...
Danaher Corporation (NYSE:DHR) is one of the 13 Best Large Cap Stocks to Buy Right Now. On May 29, Danaher Corporation ...
The stock's fall snapped a two-day winning streak.
Danaher Corp. has emerged as the leading bidder for biotechnology supplier Abcam Plc, according to people familiar with the matter. Danaher has pulled ahead of other bidders and is negotiating ...
Insights from Steven Cohen (Trades, Portfolio)'s First Quarter 2025 13F Filing. Warning! GuruFocus has detected 4 Warning ...
This was the stock's third consecutive day of losses.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback